Lista de obras - Randall J. Roper - Dominio Público Uruguay

Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner

artículo científico publicado en 2014

Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome

artículo científico publicado en 2018

Commonality in Down and fetal alcohol syndromes.

artículo científico publicado en 2013

Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice

artículo científico publicado en 2006

Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model.

artículo científico publicado en 2016

Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

artículo científico publicado en 2010

Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.

artículo científico publicado en 2004

Down syndrome mouse models have an abnormal enteric nervous system

scientific article published on 18 April 2019

Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome

artículo científico publicado en 2010

Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes

artículo científico publicado en 2017

Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses.

artículo científico publicado en 2001

Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

artículo científico publicado en 2000

Inferring gene regulatory networks from asynchronous microarray data with AIRnet.

artículo científico publicado en 2010

Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome

artículo científico publicado en 2016

Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses

artículo científico publicado en 1999

Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model

artículo científico publicado en 2015

Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.

artículo científico publicado en 2011

Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome

artículo científico publicado en 2013

Obstructive sleep apnea in young infants with Down syndrome evaluated in a Down syndrome specialty clinic

artículo científico publicado en 2015

PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome

artículo científico publicado en 2010

Perinatal loss of Ts65Dn Down syndrome mice.

artículo científico publicado en 2005

Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a

artículo científico publicado en 2015

Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits.

artículo científico publicado en 2017

The power of comparative and developmental studies for mouse models of Down syndrome

artículo científico publicado en 2007

Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice.

artículo científico publicado en 2011

Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.

artículo científico publicado en 2007

Understanding the basis for Down syndrome phenotypes

artículo científico publicado en 2006

Lista de obras de Randall J. Roper

Abnormal mineralization of the Ts65Dn Down syndrome mouse appendicular skeleton begins during embryonic development in a Dyrk1a-independent manner

Clinical identification of feeding and swallowing disorders in 0-6 month old infants with Down syndrome

Commonality in Down and fetal alcohol syndromes.

Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice

Differential effects of Epigallocatechin-3-gallate containing supplements on correcting skeletal defects in a Down syndrome mouse model.

Disruption of bone development and homeostasis by trisomy in Ts65Dn Down syndrome mice.

Down syndrome mouse models Ts65Dn, Ts1Cje, and Ms1Cje/Ts65Dn exhibit variable severity of cerebellar phenotypes.

Down syndrome mouse models have an abnormal enteric nervous system

Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome

Epigallocatechin-3-gallate (EGCG) consumption in the Ts65Dn model of Down syndrome fails to improve behavioral deficits and is detrimental to skeletal phenotypes

Genetic control of susceptibility to experimental Lyme arthritis is polygenic and exhibits consistent linkage to multiple loci on chromosome 5 in four independent mouse crosses.

Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis.

Inferring gene regulatory networks from asynchronous microarray data with AIRnet.

Influence of prenatal EGCG treatment and Dyrk1a dosage reduction on craniofacial features associated with Down syndrome

Interacting quantitative trait loci control phenotypic variation in murine estradiol-regulated responses

Low dose EGCG treatment beginning in adolescence does not improve cognitive impairment in a Down syndrome mouse model

Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn.

Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome

Obstructive sleep apnea in young infants with Down syndrome evaluated in a Down syndrome specialty clinic

PCR prescreen for genotyping the Ts65Dn mouse model of Down syndrome

Perinatal loss of Ts65Dn Down syndrome mice.

Rescue of the abnormal skeletal phenotype in Ts65Dn Down syndrome mice using genetic and therapeutic modulation of trisomic Dyrk1a

Targeting trisomic treatments: optimizing Dyrk1a inhibition to improve Down syndrome deficits.

The power of comparative and developmental studies for mouse models of Down syndrome

Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice.

Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice.

Understanding the basis for Down syndrome phenotypes